Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for UCB
Company Monitoring Page for UCB
job ratings for UCB
10/20/19
industry:
Biopharma
company:
UCB
job rating:
4
Doing the work of three people
latest headlines for company on cafepharma
J&J unwraps pivotal data on $6.5B autoimmune asset as it prepares to crash argenx and UCB's party
Fierce Biotech
Mon, 07/1/24 - 11:23 am
Tags:
JNJ
,
nipocalimab
,
myasthenia gravis
,
clinical trials
,
UCB
,
Argenx
UCB Wins FDA Approval for Plaque Psoriasis Therapy After Regulatory Setbacks
BioSpace
Thu, 10/19/23 - 10:15 am
Tags:
UCB
,
bimekizumab
,
psoriasis
,
FDA
,
Bimzelx
Finding the big spenders beyond big pharma
EP Vantage
Mon, 04/24/23 - 10:15 am
Tags:
R&D
,
Amgen
,
Bayer
,
Biogen
,
Gilead Sciences
,
Merck KGaA
,
Moderna Therapeutics
,
Novo Nordisk
,
Regeneron Pharmaceuticals
,
UCB
,
Vertex Pharmaceuticals
Big pharma holds steady on research spending
EP Vantage
Fri, 04/21/23 - 10:03 am
Tags:
R&D
,
AbbVie
,
Amgen
,
AstraZeneca
,
Bayer
,
Biogen
,
Bristol Myers Squibb
,
Eli Lilly
,
Gilead Sciences
,
GSK
,
JNJ
,
Merck
,
Merck KGaA
,
Moderna Therapeutics
,
Novartis
,
Novo Nordisk
,
Pfizer
,
Regeneron
,
Roche
,
Sanofi
,
UCB
,
Vertex Pharmaceuticals
Go or no go? Seagen's Padcev eyes FDA approval
EP Vantage
Mon, 04/3/23 - 09:41 am
Tags:
FDA
,
AbbVie
,
Alvotech
,
Ascendis Pharma
,
Astellas
,
AstraZeneca
,
Biogen
,
Daiichi Sankyo
,
Eli Lilly
,
Ferring Pharmaceuticals
,
Hugel
,
Innoviva
,
Ionis Pharmaceuticals
,
Lundbeck
,
Merck
,
Novo Nordisk
,
Otsuka
,
Pfizer
,
Roche Seagen
,
Seres Therapeutics
,
Takeda
,
UCB
,
Vertex Pharmaceuticals
Takeover-driven resurgence fails to materialize for biotech
EP Vantage
Thu, 04/14/22 - 10:41 am
Tags:
M&A
,
AbbVie
,
Biocon
,
Biogen
,
Biohaven
,
GSK
,
Halozyme Therapeutics
,
Samsung Bioepis
,
UCB
,
Viatris
Amgen, Takeda, UCB enroll first patient in Covid-19 global platform study
Pharmaceutical Business Review
Wed, 12/2/20 - 10:24 am
Tags:
COVID-19
,
pandemic
,
clinical trials
,
Takeda
,
Amgen
,
UCB
,
COVID R&D Alliance
Amgen, UCB Drug Increases Bone Density in Phase 2 Trial
Drug Discovery and Development
Fri, 01/3/14 - 12:50 pm
Tags:
UCB
,
Amgen
,
bone density
,
romosozumab
Amgen announces data from romosozumab, Prolia studies
The Fly on the Wall
Fri, 10/4/13 - 11:17 am
Tags:
Amgen
,
romosozumab
,
Prolia
,
UCB
,
bone mineral density
Top 10 rheumatoid arthritis drugs 2013
Fierce Pharma
Wed, 09/18/13 - 10:27 am
Tags:
rheumatoid arthritis
,
Humira
,
AbbVie
,
Enbrel
,
Amgen
,
Remicade
,
Janssen
,
Celebrex
,
Pfizer
,
Bristol-Myers Squibb
,
Orencia
,
Cimza
,
UCB
,
Simponi
,
JNJ
,
Arthrotec
,
Vimovo
,
AstraZeneca
,
Kineret
UCB - ConfometRx Collaborate
Yahoo/Zacks
Fri, 02/22/13 - 10:48 am
Tags:
UCB
,
ConfometRx
,
G protein coupled receptors
Lyrica matches UCB drug in Pfizer's latest epilepsy trial
Fierce Pharma
Thu, 02/21/13 - 12:34 pm
Tags:
Lyrica
,
UCB
,
epilepsy
,
Pfizer
,
Keppra
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.